health-care Logo
Claim This Company
Cara Therapeutics logo

Working At Cara Therapeutics

Zippia Score 3.3

Cara Therapeutics overview

Learn more about Cara Therapeutics, a biotechnology company focusing on pharmaceutical product development for better pruritus and pain management.
Cara Therapeutics is a small technology company based in Connecticut with only 34 employees and an annual revenue of $911,000.







Founded in



Stamford, CT


Organization Type


Is This Your Company?

The team at Cara Therapeutics

Key People
  • Josef Schoell (Executive Officer)
  • Harrison Bains (Director)
  • Dean Slagel (Director)
  • Michael Lewis (Executive Officer)
  • Frederique Menzaghi (Executive Officer)
  • Martin Vogelbaum (Director)
  • Joseph Stauffer (Executive Officer)
  • Derek Chalmers (Executive Officer, Director)
  • Jeffrey Ives (Director)

What do people say about Cara Therapeutics

Work at Cara Therapeutics ? Share your experience anonymously.

What do you like about working for Cara Therapeutics?

Cara Therapeutics Rankings

Cara Therapeutics is ranked #$81 on theBest Health Care Companies to Work For in Connecticutlist. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.

Read more about how we rank companies.


Do you Work At Cara Therapeutics?

Help us make this company more transparent.


Cara Therapeutics Financial Performance

Performance Score
We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.


< $5M

Founded in


Organization type


Cara Therapeutics Financing Rounds

DateAmountSecurity Type
Dec 11, 2014Equity
Dec 11, 2014
Jul 21, 2010Equity
Jul 21, 2010

How Would You Rate The Company Culture Of Cara Therapeutics?

Have you worked at Cara Therapeutics? Help other job seekers by rating Cara Therapeutics.

Cara Therapeutics Competitors

Frequently Asked Questions about Cara Therapeutics

When was Cara Therapeutics founded?

Cara Therapeutics was founded in 2004.

How many Employees does Cara Therapeutics have?

Cara Therapeutics has 34 employees.

How much money does Cara Therapeutics make?

Cara Therapeutics generates $911,000 in revenue.

What industry is Cara Therapeutics in?

Cara Therapeutics is in the biotechnology industry.

What type of company is Cara Therapeutics?

Cara Therapeutics is a public company.

Who are Cara Therapeutics's competitors?

Cara Therapeutics competitors include REGENXBIO, Ultragenyx Pharmaceutical, Adherex Technologies, INTRINSIC THERAPEUTICS, Tesaro, MPI Research, Ziopharm Oncology, Acadia Pharmaceuticals, Arena Pharmaceuticals, Halozyme, Inovio Pharmaceuticals, Meso Scale Diagnostics, Puma Biotechnology, NEW MEDIA INNOVATIONS, AnaptysBio, Agios Pharmaceuticals, Marcus Performing Arts Center, Nanogen, PRECISION THERAPEUTICS, Avalon Pharmaceuticals.

Who works at Cara Therapeutics?

Josef Schoell (Executive Officer)

Harrison Bains (Director)

Dean Slagel (Director)

Show More

Where is Cara Therapeutics's headquarters?

Cara Therapeutics's headquarters is in Stamford, CT.

Are you an executive, HR leader, or brand manager at Cara Therapeutics?

Claiming and updating your company profile on Zippia is free and easy.

You can find out what it is like to work at Cara Therapeutics, also known as CARA THERAPEUTICS INC, Cara Therapeutics, Cara Therapeutics Inc and Cara Therapeutics, Inc..

Zippia gives an in-depth look into the details of Cara Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Cara Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Cara Therapeutics. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions, or for the results obtained from the use of this information. The data presented on this page does not represent the view of Cara Therapeutics and its employees or that of Zippia.